Retinopathy of prematurity in surfactant treated infants.
AUTOR(ES)
Rankin, S. J.
RESUMO
Seventy six babies of less than 1500 g birth weight who had surfactant replacement therapy for severe respiratory distress syndrome were studied to assess the presence and stage of subsequent retinopathy of prematurity (ROP). A control group of 90 babies, matched for birth weight and gestational age, who did not have surfactant therapy were also studied. Threshold ROP or greater was found in 1.7% of the surfactant group and 7.8% of the controls. For the babies of less than 1000 g birth weight 4.0% of the surfactant babies and 16.3% of the controls reached threshold disease or greater. It is concluded that surfactant therapy is not associated with an increased incidence or severity of severe ROP in this preterm population.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=504227Documentos Relacionados
- Retinopathy of prematurity in a controlled trial of prophylactic surfactant treatment.
- Follow-up study on premature infants with and without retinopathy of prematurity.
- A clinicopathological case of retinopathy of prematurity (ROP) treated by peripheral cryopexy.
- Retinopathy of prematurity in infants of birth weight > 2000 g after haemorrhagic shock at birth.
- Cryotreatment of retinopathy of prematurity.